跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 97,014 条关于
“ER positive cancers”
全部
97,014
临床试验
78,747
药物
1,800
机构
295
资讯
16,172
去年
Shuttle Pharmaceuticals Secures $4.5 Million to Advance Ropidoxuridine Clinical Trials
8个月前
Megestrol Acetate Shows Dual Benefits in ER-Positive Breast Cancer Treatment
去年
Camizestrant Improves Progression-Free Survival in Advanced ER-Positive Breast Cancer
去年
MINDACT Analysis: Chemotherapy Fails to Improve Outcomes in High-Risk, Small Breast Tumors
去年
Imlunestrant Shows Promise in ER-Positive, HER2-Negative Advanced Breast Cancer
去年
Trevi Therapeutics Presents Nalbuphine ER Data at Major Respiratory Conferences Following Positive Phase 2 Trials
去年
Er-Kim and Puma Biotechnology Partner to Bring NERLYNX to Eastern Europe and Central Asia for HER2-Positive Breast Cancer Patients
去年
Camizestrant Shows Superior Progression-Free Survival Compared to Fulvestrant in ER+, HER2- Breast Cancer
去年
Niraparib and Dostarlimab Show Promise in BRCA-Mutated, ER-Positive, HER2-Negative Breast Cancer
去年
Veru Initiates Phase 2 Trial of Enobosarm Plus Abemaciclib in AR+ ER+ HER2- Metastatic Breast Cancer
第 1 页,共 1618 页
上一页
下一页